The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Outcome of recurrent osteosarcoma patients enrolled in seven phase II trials through CCG, POG, and COG: Learning from the past to move forward.
 
Joanne P. Lagmay
No Relationships to Disclose
 
Mark D. Krailo
No Relationships to Disclose
 
Ha Dang
No Relationships to Disclose
 
AeRang Kim
No Relationships to Disclose
 
Douglas S. Hawkins
No Relationships to Disclose
 
Orren Beaty
No Relationships to Disclose
 
Brigitte C. Widemann
No Relationships to Disclose
 
Theodore Zwerdling
Research Funding - GlaxoSmithKline (Inst); Jazz Pharmaceuticals (Inst); Novartis (Inst); PRAhealth sciences (Inst)
 
Lisa Bomgaars
Research Funding - Baxter (Inst); Boston Biomedical (Inst)
 
Anne-Marie Langevin
No Relationships to Disclose
 
Holcombe E. Grier
No Relationships to Disclose
 
Brenda Weigel
Travel, Accommodations, Expenses - Genentech; Lilly/ImClone; Roche/Genentech
 
Susan Blaney
Research Funding - Genentech (Inst)
 
Richard Greg Gorlick
Stock and Other Ownership Interests - Oncolytics
Consulting or Advisory Role - Oncolytics
 
Katherine A. Janeway
No Relationships to Disclose